Mallory-Denk bodies and hepatocellular senescence: a causal relationship?
Cellular senescence
Chronic cholangiopathy
Keratins
Mallory-Denk bodies
Steatohepatitis
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
26
09
2023
accepted:
22
01
2024
revised:
17
01
2024
medline:
30
1
2024
pubmed:
30
1
2024
entrez:
30
1
2024
Statut:
aheadofprint
Résumé
Mallory-Denk bodies (MDBs) are hepatocellular cytoplasmic inclusions, which occur in certain chronic liver diseases, such as alcohol-related (ASH) and metabolic dysfunction-associated (MASH) steatohepatitis, copper toxicosis, some drug-induced liver disorders, chronic cholangiopathies, and liver tumors. Our study focused on the expression of the senescence markers p21
Identifiants
pubmed: 38289501
doi: 10.1007/s00428-024-03748-1
pii: 10.1007/s00428-024-03748-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM et al (2007) From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res 313:2033–2049
doi: 10.1016/j.yexcr.2007.04.024
pubmed: 17531973
Denk H, Stumptner C, Zatloukal K (2000) Mallory bodies revisited. J Hepatol 32:689–702
doi: 10.1016/S0168-8278(00)80233-0
pubmed: 10782920
Strnad P, Stumptner C, Zatloukal K, Denk H (2008) Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol 129:735–749
doi: 10.1007/s00418-008-0431-x
pubmed: 18443813
pmcid: 2386529
Singla A, Moons DS, Snider NT, Wagenmaker ER, Jayasundera VB, Omary MB (2012) Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria. Hepatology 56:322–331
doi: 10.1002/hep.25664
pubmed: 22334478
Hanada S, Harada M, Abe M, Akiba J, Sakata M, Kwan R et al (2012) Aging modulates susceptibility to mouse liver Mallory-Denk body formation. J Histochem Cytochem 60:475–483
doi: 10.1369/0022155412441478
pubmed: 22473941
pmcid: 3393076
Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L et al (2002) p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160:255–263
doi: 10.1016/S0002-9440(10)64369-6
pubmed: 11786419
pmcid: 1867135
Stumptner C, Fuchsbichler A, Zatloukal K, Denk H (2007) In vitro production of Mallory bodies and intracellular hyalin bodies: the central role of sequestosome 1/p62. Hepatology 46:851–860
doi: 10.1002/hep.21744
pubmed: 17685470
Nakajima T, Nakashima T, Okada Y, Jo M, Nishikawa T, Mitsumoto Y et al (2010) Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: comparison with telomere-specific quantitative FISH and p21 immunohistochemistry. Pathol Int 60:175–183
doi: 10.1111/j.1440-1827.2009.02504.x
pubmed: 20403043
Stumptner C, Fuchsbichler A, Lehner M, Zatloukal K, Denk H (2001) Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. J Hepatol 34:665–675
doi: 10.1016/S0168-8278(00)00099-4
pubmed: 11434612
Sharpless NE, Sherr CJ (2015) Forging a signature of in vivo senescence. Nat Rev Cancer 15:397–408
doi: 10.1038/nrc3960
pubmed: 26105537
Aravinthan AD, Alexander GJM (2016) Senescence in chronic liver disease: is the future in aging? J Hepatol 65:825–834
doi: 10.1016/j.jhep.2016.05.030
pubmed: 27245432
He S, Sharpless NE (2017) Senescence in health and disease. Cell 169:1000–1011
doi: 10.1016/j.cell.2017.05.015
pubmed: 28575665
pmcid: 5643029
Herranz N, Gil J (2018) Mechanisms and functions of cellular senescence. J Clin Invest 128:1238–1246
doi: 10.1172/JCI95148
pubmed: 29608137
pmcid: 5873888
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al (2005) Design and validation of a histological scoring system fo nonalcoholic fatty liver disase. Hepatology 41:1313–1321
doi: 10.1002/hep.20701
pubmed: 15915461
Ludwig J, Batts KP (1998) Practical liver biopsy interpretation. Diagnostic algorithms, 2nd edn. American Society of Clinical Pathologists Press, Chicago
Torbenson MS, Ng IOL, Park YN, Roncalli M, Sakamoto M (2019) Hepatocellular carcinoma. WHO classification of tumours: digestive system tumours, 5th edn. International Agency for Research on Cancer, Lyon, pp 229–239
Denk H, Pabst D, Abuja PM, Reihs R, Tessaro B, Zatloukal K et al (2022) Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results. Mod Pathol 35:87–95
doi: 10.1038/s41379-021-00940-5
pubmed: 34645984
Sato K, Meng F, Glaser S, Alpini G (2018) Cellular senescence in cholestatic liver injury. J Exp Res Human Growth Aging 1:1–6
Sato K, Marzioni M, Meng F, Francis H, Glaser S, Alpini G (2019) Ductular reaction in liver diseases: pathological mechanisms and translational significances. Hepatology 69:420–430
doi: 10.1002/hep.30150
pubmed: 30070383
Papatheodoridi AM, Chrysavgis L, Koutsilieris M, Chatzigeorgiou A (2020) The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology 71:363–374
doi: 10.1002/hep.30834
pubmed: 31230380
Meijnikman AS, Herrema H, Scheithauer TPM, Kroon J, Nieuwdorp M, Groen AK (2021) Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. JHEP Rep 3:100301. https://doi.org/10.1016/j.jhepr.2021.100301.eCollection2021
doi: 10.1016/j.jhepr.2021.100301.eCollection2021
pubmed: 34113839
pmcid: 8170167
Ferreira-Gonzalez S, Rodrigo-Torres D, Gadd VL, Forbes SJ (2021) Cellular senescence in liver disease and regeneration. Semin Liver Dis 41:50–66
doi: 10.1055/s-0040-1722262
pubmed: 33764485
Pinto C, Ninfole E, Gaggiano L, Benedetti A, Marzioni M, Maroni L (2020) Aging and the biological response to liver injury. Semin Liver Dis 40:225–232
doi: 10.1055/s-0039-3402033
pubmed: 31887774
Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255–260
doi: 10.1002/hep.510310201
pubmed: 10655244
Tischoff I, Tannapfel A (2008) DNA methylation in hepatocellular carcinoma. World J Gastroenterol 21:1741–1748
doi: 10.3748/wjg.14.1741
Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H (1999) p16
doi: 10.1016/S0016-5085(99)70137-X
pubmed: 9922321
Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H (2000) p16 is a major inactivation target in hepatocellular carcinoma cancer 89:60–68. https://doi.org/10.1002/1097-0142(20000701)89:13.0.co;2-3
Zang J, Fang X, Xu J, Oin Y, Shen R, Yang Y et al (2011) P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis. World J Gastroenterol 17:3043–3048
doi: 10.3748/wjg.v17.i25.3043
pubmed: 21799651
pmcid: 3132256
Zhang C, Li J, Huang T, Suan S, Dai D, Jiang D et al (2016) Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma. Oncotarget 7:81255–81267
doi: 10.18632/oncotarget.13221
pubmed: 27835605
pmcid: 5348390
Sturmlechner I, Zhang C, Sine CC, van Deursen EJ, Jeganathan KB, Hamada N et al (2021) p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science 374:eabb3420. https://doi.org/10.1126/science.abb3420
doi: 10.1126/science.abb3420
pubmed: 34709885
pmcid: 8985214
Chen Z, Tian R, She Z, Cai J, Li H (2020) Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 152:116–141
doi: 10.1016/j.freeradbiomed.2020.02.025
pubmed: 32156524
Martin N, Zhu K, Czarnecka-Herok J, Vernier M, Bernard D (2023) Regulation and role of calcium in cellular senescence. Cell Calcium 110:102701
doi: 10.1016/j.ceca.2023.102701
pubmed: 36736165
Öhlinger W, Dinges HP, Zatloukal K, Mair S, Gollowitsch F, Denk H (1993) Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis. Virchows Arch A Pathol Anat Histopathol 423:169–176
doi: 10.1007/BF01614767
pubmed: 7694422
Desmet VJ (2009) The amazing universe of hepatic microstructure. Hepatology 50:333–344
doi: 10.1002/hep.23152
pubmed: 19642165
Desmet VJ (2011) Ductal plates in hepatic ductular reactions. Hypothesis and implications. III. Implications for liver pathology. Virchows Arch 458:271–279
doi: 10.1007/s00428-011-1050-9
pubmed: 21301864
Chiba M, Sasaki M, Kitamura S, Ikeda H, Sato Y, Nakanuma Y (2011) Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. J Clin Pathol 64:564–570
doi: 10.1136/jcp.2011.090175
pubmed: 21486894
Guicciardi ME, Trussoni CE, LaRusso NF, Gores GJ (2020) The spectrum of reactive cholangiocytes in primary sclerosing cholangitis. Hepatology 71:741–748
doi: 10.1002/hep.31067
pubmed: 31833071
Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A et al (2017) Cellular senescence drives age-dependent hepatic steatosis. Nat Comm 8:15691. https://doi.org/10.1038/ncomms15691
doi: 10.1038/ncomms15691
Tabibian JH, O’Hara SP, Splinter PL, Trussoni CE, LaRusso NF (2014) Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 59:2263–2275
doi: 10.1002/hep.26993
pubmed: 24390753
Gouw AS, Clouston AD, Theise ND (2011) Ductular reactions in human liver: diversity at the interface. Hepatology 54:1853–1863
doi: 10.1002/hep.24613
pubmed: 21983984
Aguilar-Bravo B, Rodrigo-Torres D, Arino S, Coll M, Pose E, Blaya D et al (2019) Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis. Hepatology 69:2180–2195
doi: 10.1002/hep.30472
pubmed: 30565271
Rakoski MO, Brown MB, Fontana RJ, Bonkovsky HL, Brunt EM, Goodman ZD et al (2011) Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 9:902–909
doi: 10.1016/j.cgh.2011.07.006
pubmed: 21782771
pmcid: 3400531
Basaranoglu M, Turhan N, Sonsuz A, Basaranoglu G (2011) Mallory-Denk bodies in chronic hepatitis. World J Gastroenterol 17:2172–2177
doi: 10.3748/wjg.v17.i17.2172
pubmed: 21633525
pmcid: 3092867
Kayacetin S, Basaranoglu M (2015) Mallory-Denk bodies: correlation with steatosis, severity, zonal distribution, and identification with ubiquitin. Turk J Gastroenterol 26:506–510
doi: 10.5152/tjg.2015.150199
pubmed: 26507848